COPD, the third leading cause of death globally, affects an estimated 12.5 million people in the US, leading to 150,000 deaths annually.

The disease is also one of the most expensive chronic conditions, generating healthcare costs of over $30 billion per year in the US. Much of that cost is driven by exacerbations, the sudden and life-threatening deterioration in lung function experienced by COPD patients.